The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the U.S.
In a study in the open access journal PLoS Medicine, Marc-André Gagnon and Joel Lexchin make the case for a new estimate of promotional expenditures in the pharmaceutical industry. They used databases to make a revised estimate and compared their results with those from other data sources to argue in favor of changing the priorities of the industry.
Gagnon and Lexchin compared data from IMS, the usual authority for assessing promotional expenditures, with data from CAM, a market research company that provides information on promotion expenditures by surveying doctors instead of firms. When the analysis was finished, the revised estimate for promotional spending in the US was more than twice than what IMS reported.